The RSPCA has reported a dramatic increase in the number of cats being abandoned.
The number of abandonments reported to the RSPCA was 10,610 in 2010, a 28% increase on the number reported in 2009 (8,310), and a 40% increase on the number in 2008 (7,609).
The charity received 205 reports of cats being shot in 2010, more or less the same as the year before. However, the charity says anecdotal reports suggest the number of cats being attacked (including being set upon by dogs or thrown from buildings) is increasing.
RSPCA chief veterinary officer, Alastair Macmillan, said: "The news of massive rises in abandonments and other attacks is alarming and shows a frightening trend in cat abuse and neglect. We don't know why we are seeing such increases and hope that people are not starting to see cats as worthless things which can be targeted with weapons or just dumped when people don't want to care for them anymore".
Part of the VN Futures project, the lunchtime webinars will be delivered between February and June 2020 via the Webinar Vet, and the College is encouraging all veterinary surgeons, nurses, practice managers and owners to attend, as it says the webinars will benefit the whole practice team.
All three webinars take place at 12.30pm and last one hour. They are as follows:
Tuesday 4 February 2020 – ‘Maximising the potential of the veterinary nurse’ presented by Louise Northway RVN, BVNA Council member and recipient of the RCVS Inspiration Award. The webinar will give an overview of the role of veterinary nurses under Schedule 3 of the Veterinary Surgeons Act, how VNs can develop their role in practice and take on extra responsibilities and how VNs can approach these conversations in practice through the creation of learning and development plans. This webinar will illustrate how fully utilising the nursing team not only hugely boosts the morale of the work force, but also enhances patient care and increases the efficiency of the business.
Tuesday 10 March 2020 – ‘Veterinary nurses’ time is valuable: How and why to charge for it’ presented by Stephanie Writer-Davies MRCVS, Career Progression Working Group member, and Jane Davidson RVN, VN Council member and regular blogger on veterinary nursing issues. This webinar will provide examples and case studies of how veterinary nurses contribute to practice finances, how practice pricing structures can be developed so that the financial value of veterinary nurses’ time and effort can be better highlighted, and how veterinary nurses can demonstrate their value to clients.
Tuesday 23 June 2020 – ‘Lead or Head RVN: What’s in a name?’ presented by Gillian Page RVN, President of the Veterinary Management Group. This webinar will look at the role of the traditional Head RVN and how development of ‘Lead RVNs’ in different areas of practice can help to allow for growth of other talented team members and provide increased and shared responsibility and progression. This webinar will explore how this enhances practice efficiency alongside development of team members, thus increasing job satisfaction and, ultimately, retention.
Racheal Marshall, Chair of RCVS Veterinary Nurses Council and the VN Futures Board, said: "We hope that veterinary nurses will engage with these webinars in order to gain some inspiration about how they can truly show their value to their team, their clients and the wider public.
"The VN Futures research clearly demonstrated that there was a desire from the veterinary nursing profession to find ways in which VNs could gain greater recognition for the work they do and progress in their careers. These webinars, and our talented presenters, will provide many practical examples and case studies on how this can be done, help build confidence and highlight opportunities for further learning and development."
To sign up to the free webinars, visit: https://www.thewebinarvet.com/sponsors/VN%20Futures.
The oral corticosteroid powder formulation was previously only available in 180g tubs.
Severe equine asthma, which was previously known as Recurrent Airway Obstruction (RAO), Chronic Obstructive Pulmonary Disease (COPD) or Heaves, can lead to airway neutrophil influx and excessive mucus production. Although it is generally managed by environmental measures to suppose triggering factors, it can be combined with corticosteroid therapy to control airway inflammation in more severe cases.
Alana McGlade BVMedSci BVM BVS MRCVS, Equine Business Manager, said: "Severe equine asthma is the most common cause of chronic coughing in mature horses. Attributed to a hypersensitivity to inhaled allergens and dust, clinical signs - such as inflammation of the airways - can be alleviated by Equisolon’s active ingredient prednisolone.
"Prednisolone has been shown to have positive effects on clinical signs, endoscopic evaluation, arterial blood gases and pulmonary function when used in conjunction with environmental changes to reduce a horse’s exposure to potential triggers.
"Previously, vets would have had to measure out the powder but the sachets make dosing more convenient. The sachets come in a box of 10, so each pack will treat one 300 kg horse for 10 days or one 600 kg horse for 5 days. As the sachets are pre-measured, horses get exactly the dose they need.”
Equisolon oral powder contains 33.3 mg/g of prednisolone and should be administered at 1 mg prednisolone per kg of body weight per day. Treatment can be repeated at 24 hour intervals during 10 consecutive days.
For more information visit www.dechra.co.uk
DuoTox is the first product to combine activated charcoal and diosmectite, providing a wider spectrum of absorbency against various toxic substances.
Accidental poisoning poses a significant threat to pets, with vets in the UK reporting over 30001 cases a week and making an average 60 calls a day to the VPIS for assistance2
In 2020, 7.1 million pets fell ill after eating something poisonous1 and the VPIS reported a 40% increase in poisoning enquiries in 20212.
The most commonly used product for accidental ingestion is activated charcoal, but it only has affinity for certain substances.
Diosmectite also only binds to select substances, but is not as widely used.
Up until now, the two have not been used together in one product, leaving situations where the chosen binder has no effect.
NVS says that in cases of potential ingestion, identifying the exact substance consumed, and relying on vets to know which binder to use for each substance, is a barrier to successful toxin binding.
Malcolm Dickinson, Category Manager for Select from NVS, said: “Activated charcoal has affinity for substances that are, for example acidic, non-ionised or poorly water soluble, leaving a gap for substances that are alkaline, cationic, hydrophilic etc.
"This is where the absorbency profile of diosmectite comes in to create one product with a much wider spectrum of adsorbency.”
“This will be hugely beneficial to vets in practice: vets can reach for one product, knowing it will be effective.”
DuoTox is available in both paste and liquid forms, designed with palatability in mind.
https://www.nvsweb.co.uk/product-brand/select-healthcare/
References:
The changes are designed to make the process more accessible and the College says most were proposed as a result of candidate feedback. They are:
The changes will come into effect from 1 January 2025, in time for the 2025 Stat Exam cohort.
Dr Linda Prescott-Clements, RCVS Director of Education, said: “We have been listening to the concerns of various stakeholders, including those who have undertaken the Stat Exam previously and veterinary employers, and we used this feedback to work with the Department for Environment, Food & Rural Affairs (Defra) to come up with a set of practical, deliverable changes that improve the experience of Stat Exam for all candidates, and hopefully alleviate some of the stress involved around timescales, opportunity and finance.
“These changes will make the exam more accessible, as it will allow candidates to have two attempts at the written papers within the same diet, which need to be passed before being allowed to proceed to the practical exam and it will also help improve accessibility to the exam from the perspective of candidate finances.
www.rcvs.org.uk/statutory-membership-exam
The gallery was traditionally held in-person at the NAVC’s annual Veterinary Expo & Meeting (VMX) in Florida.
Now, for the first time since it began in 2012, the gallery is accessible to everyone everywhere months before the live event in June.
The new Virtual VMX New Product Gallery went live this week and will run until 3rd September 2021. It showcases 21 new product innovations from the following companies: BioNote; Boehringer Ingelheim Animal Health; Dechra Veterinary Products; Epicur Pharma; GVL; Hill’s Pet Nutrition, Inc.; Merck Animal Health; Neogen Corporation; Ogena Solutions; Purina; Royal Canin; Vetoquinol; Zoetis Petcare.
NAVC CEO Gene O’Neill said: "Each year, NAVC’s panel of experts select the most innovative new products and services to be showcased as part of the VMX Expo. We are excited to take this VMX staple and, for the first time, make it universally available to members of our global veterinary community everywhere.
"And they don’t have to wait until June to learn about and try these important new products. The VMX Virtual New Product Gallery launch is part of the NAVC’s expanding virtual portfolio which breaks down barriers of geography and time to make the best products the veterinary industry has to offer available to veterinary professionals worldwide.” The gallery is free to access. You can register here: https://vmxvirtual.simexpo.com/page/100
The aim of the week is to help pet owners identify common symptoms of eye disease and to seek prompt veterinary attention where appropriate.
To support the initiative, TVM UK is supplying veterinary practices with a kit to create their own waiting room display to inform owners about the common symptoms of eye disease. Pet owners can obtain further, more in-depth information by scanning a QR code on their smartphone camera which takes them directly to the webpage www.tvm-uk.com/eyehealth.
There is also a ‘Who’s Got Their Eye on You’ mini quiz to help engage clients to see if they can spot one of their pets in the animal line up.
Will Peel, Product Manager at TVM UK said: "Eye problems in pets can sometimes be hard for pet owners to pick up so we have launched Pet Eye Health Awareness Week to raise awareness of common symptoms of poor eye heath so problems can be identified early and pet owners can seek veterinary advice quickly."
For more information, contact your local territory manager, email help@tvm-uk.com or call 0800 0385868. You can find additional eye-health related social media content at: www.tvm-uk.com.
Dr Guillaume Leblond, an American specialist in veterinary neurology at NDSR said: “Traditionally, bone cement has been used to provide support and stabilisation when treating veterinary spinal instability cases.
“Polyaxial pedicle screws have proven a very reliable and efficient way of treating such spinal problems in human medicine.
“These special screws can be inserted in the vertebrae and connected to strong metal rods instead of bone cement and we’re now very excited to be offering this new service to our patients.
“The main advantage to this cutting-edge procedure is its flexibility.
"Once cement is set in place it is obviously very hard to move, manipulate or remove should you need to adjust or correct.
“With the metal rod and screw system, it is more adaptable and you can adjust it far more easily and quickly.
“It may also be less prone to infection compared to cement, which has been known to harbour bacteria sometimes causing infections several years after the surgery.
"Another hope we have for this system is that it will be less prone to failure compared to cement, especially on extended stabilisation constructs.
Guillaume added: “The neurology team at NDSR has been training in applying this new system as soon as it became available and we have already used it to treat two dogs, both of them having surgery on the same day.
“One was a golden retriever treated by my colleagues Rodolfo Cappello (head of neurology) and Natalie West (neurology resident), and the other was a whippet under my care.
"They were two very different sizes of dog but both operations went well.
“We are grateful to OrthomedTM, the company manufacturing the stabilization system, provided all necessary details to plan the surgeries as precisely as possible.
“We also collaborated with Vet3DTM to create patient specific 3D printed guides to ensure the precise placement of screws and it proved a great solution in both cases.”
“Admittedly, it is still early days for the introduction of this new spinal stabilisation system but we are optimistic it will prove a significant advancement in treating many spinal problems.”
www.ndsr.co.uk
MSD Animal Health (Merck in the US and Canada), has launched Finadyne (flunixin), the NSAID for cattle, as a pour on.
According to the company, Finadyne Transdermal is the world's first non-parasiticide cattle product to be made available as a pour-on.
Dr. Martin Behr, technical manager at MSD Animal Health said: “Finadyne Transdermal is uniquely designed for rapid absorption into the bloodstream and its antipyretic effect has been demonstrated as early as two hours after treatment. This is because innovative penetration enhancers are included in the formulation to improve the absorption of the active ingredient flunixin through the skin.”
The new product comes in pre-calibrated packaging and uses a bottle designed for easy application along an animal’s back.
Dr. Behr added: “It’s much simpler for farmers to treat cattle in this way – as opposed to administering an injection, which can also mean needle-site lesions that can reduce the value of a carcass or compromise hide quality.
“The time taken to handle and treat animals will be much reduced with a transdermal NSAID. There will also be a saving on syringes and needles.”
Finadyne Transdermal (POM-V) is available now from veterinary wholesalers. Further information is available from the MSD Animal Health veterinary support group on 01908 685685.
The web based app, which has been launched in association with the BSAVA, provides a library of medical summaries drawn from global guidelines and peer-reviewed journals.
Vet2Vet co-founder Dr Zoe Coker said “There is rarely time during the working day to read all the necessary journals, articles and up-to-date texts. VETbytes collates all the evidence on a specific medical condition and consolidates it into a short synopsis called a Keep it Simple Summary (KISS)."
BSAVA President Professor Ian Ramsey said: “BSAVA is excited and proud to be involved in the VETbytes project, which should provide significant benefits and support for our members. Every busy small animal clinician should try out VETbytes as it is a real paradigm shift in mobile resources for vets.”
The VETbytes app currently covers more than 100 topics developed in consultation with more than 25 veterinary experts. Further benefits include drug (and CRI) calculators, a quick reference section and links to hundreds of source abstracts. The content encourages reflective learning and can be used towards CPD hours.
VETBytes is available on subscription with reduced rates for BSAVA members and free access for veterinary students.
To start a free trial or subscribe to the VETbytes app, visit www.vetbytes.co.uk.
The specialist-led lectures will start on 5th May and run until October 2021, with a session every couple of weeks, alternating between vets and nurses.
RCVS-recognised specialist in ECC, Tobias Grave, and Racheal Marshall RVN, head of clinical nursing at Vets Now, are among the speakers who will be covering topics such as damage control resuscitation, traumatic brain injury and neurotoxins. You can view the full programme here.
Dan Lewis, ECC specialist at Vets Now, who devised this year’s veterinary CPD programme, said: “Because emergencies don’t only happen out of hours we’re committed to working with general practitioners to deliver the best possible care to pets at the time they need it most. With that in mind, we are also committed to bringing relevant and pioneering CPD and training to veterinary clinicians and vet nurses.
“As emergency and critical care experts, we appreciate the value of flexibility and are always looking to adapt our services. In 2021, with social distancing still expected to be the norm, we’re offering two CPD streams, available live and on-demand.
“We delivered a successful interactive learning experience for virtual delegates through our ECC Congress at the end of last year, so we have a strong foundation from which to build on innovative and expert virtual CPD, and we’ll aim to leave delegates feeling well-informed and assured.
“We will obviously miss seeing everyone in person but gathering together online like this is beneficial as we can reach more vets and vet nurses with valuable CPD. Importantly, the format can fit around busy schedules, with all content available as videos after the events have taken place.”
Dan added: “Delegates from our ECC Congress commented on some added benefits of the virtual format including things like less environmental impact and waste through less travelling, and more flexibility due to being able to look back on the content after the event. Delegates also felt it was easier to ask questions of the speakers without feeling intimidated.”
The event series is priced at £72 for the vet stream (working out at £12 per session) and £60 for the vet nurse stream (£10 per session). You can also attend both for £110 (working out at £9.16 per session).
You can book your place at www.vets-now.com/bitesize.
The plenary speaker was Professor Rory O’Connor, Chair of Health Psychology at the University of Glasgow’s Institute of Health & Wellbeing whose talk: "When it is darkest: understanding suicide risk" opened the day with an outline of his 25 years of work looking into suicide prevention.
Rory discussed his recent investigation into the impact of the Covid-19 pandemic on people’s mental health and wellbeing, and how to reduce the risk of suicidal ideation turning into suicidal action.
He said: “In the last 10 to 15 years there has been an increased focus in particular on psychological and psycho-social interventions for helping people who are suicidal.
"Although suicide is complex, interventions, even brief interventions, can be effective.”
Rory was followed by presentations from a number of teams, including those who'd been awarded the MMI’s Sarah Brown Mental Health Research Grant in 2019 and 2020:
The full report of the day’s talks can be found here https://www.vetmindmatters.org/resources/report-mind-matters-initiative-research-symposium-2021
Nick Stace, CEO of the Royal College of Veterinary Surgeons (RCVS), has issued a swift and robust response to the call by Unite for a shake up for the profession's regulatory system.
"Unite's suggestion that veterinary regulation should be under the scrutiny of the Professional Standards Authority (PSA) is misguided, because the PSA is there to oversee regulation in the human healthcare sector and the RCVS already has Department for Environment, Food and Rural Affairs (Defra) and Privy Council oversight.
"Its further thoughts around the RCVS disciplinary process are out of date and missing the point. We would be very happy to help put them right and to hear any legitimate concerns they may have.
"Unite is calling for the College to no longer 'set the rules and hand down judgments', when in fact last year we successfully achieved a Legislative Reform Order, backed by the profession, to ensure that our Disciplinary and Preliminary Investigation Committees will become independent from Council.
"Unite also talks about the profession's disquiet about last year's Disciplinary Hearing into Mr Chikosi, something we are well aware of and are currently responding to by looking at the biggest area of concern, the provision of 24/7 emergency cover. Our fact-finding mission is seeking views from the profession and the public.
"More broadly, though, feedback from our First Rate Regulator initiative has shown that the profession does have confidence in our disciplinary procedures and that they are certainly not subject to 'long-standing discontent'.
"The First Rate Regulator initiative is also leading to significant improvements in the way that complaints are handled, including speed to resolution.
"Unite is seeking to recruit members of the veterinary team as members of its union and it may be more successful in that pursuit if it was to start to understand the profession better, perhaps beginning with getting its facts right.
"We would be delighted to meet with Unite to put them right where they are factually wrong, and hear what they have to say."
MSD Animal Health has announced the launch of The Big Tick Project, both to investigate whether ticks are carrying more pathogens and to raise awareness amongst the public.
The company highlights research which shows that nationally, tick distribution has expanded by 17% in the last 10 years and tick numbers have also increased in 73% of locations surveyed.1 In addition, the company says there is evidence that ticks are feeding earlier in the year and feeding for longer2, thus increasing their potential to pass on significant disease to both animals and humans. Lyme disease in particular can be serious health issue for both humans and animals, being increasingly recognised and recorded in the UK recent years3.
So, as part of the project, practices are being invited to collect ticks and send them to the University of Bristol for analysis. In addition, there'll be a national PR and marketing campaign fronted by the naturalist Chris Packham (pictured right).
Practices taking part in the project will receive a tick collection kit and marketing support pack including access to dedicated PR services, postcards and posters to raise awareness of ticks within their clinic and local community. The collection kit includes instructions, collection equipment and Freepost packaging to allow ticks removed from dogs to be sent to the university quickly and easily.
Professor Richard Wall from University of Bristol said: "For accurate results we need as many ticks as possible and I really encourage vet practices up and down the country to get involved. We need data from all types of practices ranging from urban to rural locations to help vets and human health professionals make more effective recommendations and help prevent tick-related disease."
To take part in The Big Tick Project, email a contact name and your practice details to: info@bigtickproject.co.uk.
References
At the outset of the hearing, Mr Kashiv, from Vets & Pets, Broxbourne, denied all aspects of the charges against him. During the course of the inquiry, some heads of charge were not pursued and some he admitted, leaving the remaining heads of charge to be determined.
The charges concerned the treatment of a Scottish Terrier, called Tanzy, whose owner, Mrs Greenhill, brought her in to see Mr Kashiv on 5 March 2015. Mrs Greenhill was concerned about blood in Tanzy’s urine and swellings in her mammary glands. After carrying out a cytopathology test, Mr Kashiv advised Mrs Greenhill that Tanzy would require surgery to remove the mammary glands. There were no further tests conducted, and no alternatives to surgery suggested.
On 13 March another veterinary surgeon at Vets & Pets therefore undertook a right-side mammary strip on Tanzy, discharging her the following day. On 17 March Mrs Greenhill brought Tanzy back in for a post-operative check and was seen by a locum veterinary surgeon, who found her to be in good condition.
On 20 March Mrs Greenhill then became concerned about Tanzy’s deteriorating condition and returned her to see Mr Kashiv. He admitted Tanzy for observation over the weekend but did not conduct any further tests at that stage, apart from radiography on 22 March. The hospitalisation records were of poor quality and substantially incomplete.
On 23 March Mr Kashiv then informed Mrs Greenhill that Tanzy could be discharged, although he recommended an MRI scan to assist in the diagnosis; this was declined on cost grounds. He did not however explain clearly to Mrs Greenhill that Tanzy’s prognosis was bleak, and did not give adequate home care instructions.
Tanzy continued to deteriorate, and on 24 March Mrs Greenhill took Tanzy to the RSPCA Harmsworth Hospital where a veterinary surgeon conducted tests which showed that Tanzy was in renal failure. The veterinary surgeon then called Mrs Greenhill and recommended that Tanzy was put to sleep, which was then performed in Mrs Greenhill’s presence.
The Committee found that Mr Kashiv had failed to conduct the necessary investigations when Tanzy was admitted from 20 to 23 March 2015, being satisfied that, by the time Tanzy had been hospitalised for a period of three days, it was mandatory for a blood test to have been performed, given her marked deterioration.
The Committee also found while Mr Kashiv did express his opinion that Tanzy’s prognosis was poor, he did not give the full explanation required in the circumstances of this case to enable Mrs Greenhill to understand fully the prognosis. The Committee also considered that Tanzy was not in a fit state to be discharged on 23 March 2015, and that he had failed to keep sufficiently clear and/or detailed and/or accurate records.
After full consideration, the Committee found that Mr Kashiv’s actions amounted to serious professional misconduct, and was satisfied that his actions fell far short of the conduct to be expected of a reasonably competent veterinary surgeon in respect of heads of charge 1, 2 and 3 but not 4.
Although it was concerned "about the culture of care in the practice, in particular not having in place proper protocols and procedures and without necessary support from properly trained staff", in deciding on appropriate sanction, the Committee was satisfied that there were "a number of serious misjudgements by Mr Kashiv in this case".
The Committee decided to postpone judgement for a period of two years, whilst recommending that Mr Kashiv agree to undertake a structured programme to benefit his clinical practice including a Personal Development Plan, mentoring, practice visits, additional CPD and regular reports to the Disciplinary Committee.
Non-compliance with these undertakings may result in the hearing being resumed at a date earlier than the two-year period.
Stuart Drummond, Chairing the Disciplinary Committee and speaking on its behalf, said: "The Committee considers that Mr Kashiv is a dedicated veterinary surgeon, as evidenced by the large number of testimonials, and that he provides a valuable service to the community, particularly with rescue animals.
"Nevertheless, the Committee considers that there were a number of fundamental failings in Mr Kashiv’s clinical competence which are required to be addressed during the period of postponement. For the reasons set out above the Committee considers that Mr Kashiv’s clinical practice will benefit from a structured programme over the period of postponement, whilst protecting the welfare of animals, maintaining public confidence in the profession and declaring and upholding proper standards of conduct."
For the full charges, findings and decisions, see: http://www.rcvs.org.uk/concerns/disciplinary-hearings/
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
The theme for this year's event, which takes place on 7th November, is the cornea. Lectures will include 'Medical Cornea', 'Cross Linking' and 'Surgical Cornea'. There will be Q&A sessions after each one.
Amongst the speakers are Chris Dixon, CertOphthal MRCVS MRCVS from Veterinary Vision Ophthalmic referrals, Christine Heinrich, RCVS & European Specialist in Veterinary Ophthalmology from the Eye Clinic and Sara Thomasy, Professor of Comparative Ophthalmology at the University of California from UC Davis University.
As is customary, abstracts will be presented throughout the day.
Tickets are £100 +VAT, or £60+Vat for students, interns and veterinary nurses: https://www.thewebinarvet.com/pages/bravo-virtual-winter-conference-2020-tickets/
The company announced last month that from 1st January next year, practices will have to order companion animal and ruminant products via either MWI or NVS (who will also fulfil the order), but will be invoiced direct by MSD.
Pig products will join aquaculture and poultry products to be supplied directly to customers by MSD Animal Health.
In its announcement, the company said that the new structure would allow the company to enhance the customer experience and more quickly adapt to changes in the market to better serve its customers.
VetSurgeon.org contacted the company for further clarification about how the customer experience would be improved.
The company explained that the two main benefits of the new structure concern price visibility and stock control.
A spokesperson for the company said: "Currently, customers may get a discount from us and separately a discount from wholesaler. With our new distribution model we will invoice monthly and all discounts will be on one invoice, so it will be easier to determine the actual price paid."
The spokesperson explained that with the old model, once stock was sold to wholesalers it would be allocated to customers, so there would be some held by MSD, some allocated and some in distribution: "The benefit of the new model is we will have full oversight of stock as it will be in our own warehouses or with distribution partners. If there are disruptions in the market, we will have better awareness of in market demand and we can allocate stock appropriately".
The PIC decision marked the conclusion of its investigation into a concern that was raised formally last November involving allegations of bullying at Professor Argyle’s workplace, the University of Edinburgh.
Professor Argyle, who had previously decided to step aside from his JVP and Council duties until the concern was investigated and concluded, said: “Despite this outcome from the PIC discussions, I have now made the challenging decision to stand down from my position at the RCVS. This is to ensure there is no further distraction to the College’s important work and activities and that whoever becomes the next JVP has the full support of Council and RCVS members.
"It is also to reduce the toll this situation has taken on my family, colleagues and students, and on me personally. I am proud and privileged to have served on RCVS Council for nearly ten years and wish it well as it navigates the next chapter in its history."
RCVS President Mandisa Greene said: “I appreciate that this has been an exceptionally difficult situation and very upsetting for all involved.
"I understand why David has taken the difficult decision to stand down from RCVS Council and would like to thank him for his many years of service to the RCVS since joining Council in 2012.
"I would also like to reassure colleagues once again that, throughout, the College has remained firmly committed to following due, proper and fair process in all its regulatory activities."
Following Professor Argyle’s decision to step down, the process for electing a new JVP for the current presidential year will commence.
As Professor Argyle was a Veterinary Schools Council appointee on RCVS Council, it will be for that body to elect a replacement Council member.
Further details will be announced in due course.
The study1 took the form of an online survey of over 5,500 owners, which exploring the the early socialisation, health and behaviour of ‘pandemic puppies’ purchased in 2020 compared to 2019 puppies.
The study found that puppies bought during the pandemic in 2020, in comparison to pre-pandemic in 2019, were more likely to have been ‘designer crossbreeds’, for example a Cockapoo or Cavapoo, instead of Kennel Club registered purebred dogs.
The 2020 cohort of pandemic puppies were also more likely to already hold a pet passport at purchase, indicating they may have been imported from Europe – perhaps illegally – to meet the greatly increased demand and prices for puppies.
Amongst the positive findings was the fact that many of the health and socialisation experiences examined didn’t vary significantly between puppies purchased in 2019 and 2020.
However, researchers say there was still a concern that 2020 ‘pandemic puppies’ were less likely than 2019 puppies to attend puppy training classes or to have experienced visitors to their homes (under the age of 16 weeks in both circumstances).
This, they say, means pandemic puppies may be more likely to experience stranger-related fear and anxiety and other behavioural problems related to insufficient socialisation, from being unable to attend puppy classes under 16 weeks of age; a critical period for the development of puppies.
In addition, those puppies sourced from Europe may have been transported over long distances without their mother, a stressful experience which the researchers say could cause problem behaviours in the future.
Pandemic puppies may therefore need extra support from the veterinary profession, particularly those specialising in animal behaviour.
Dr Claire Brand, Researcher in Canine Welfare at the RVC said: “Despite many owners’ concerted efforts to raise their puppies as well as possible, some puppies missed out on key experiences of puppyhood, such as going to puppy classes, or experiencing visitors in their homes.
"This has potential consequences for the future behaviour of ‘pandemic puppies’ and so we are encouraging owners to seek out training and behaviour advice from accredited professionals so that these now adult dogs can learn to live happily in our post-lockdown world.”
Reference
The company surveyed 1979 pet owners last December and found the main reason they didn’t take their cat to the vet more often was because the animal appeared to be healthy and therefore didn’t need medical attention.
The second biggest barrier to more regular vet visits was cost. Although almost half of the cat owners surveyed had pet insurance, almost a quarter said cost prevented them from taking their cat to the vet more often.
Despite there being 760 cat-friendly clinics across the UK and Ireland, 13% percent of owners said the stress put them off making more frequent trips to the vet.
If they were unable to take their cat to the vet, 40% said they would arrange for a vet home visit, 29% said they would search for information online and 26% would turn to friends and family for advice.
The survey also found that 11% of owners believed that their cat was overweight. However, according to a 2018 study, 39% of cats are overweight in the UK, which would suggest that over a quarter of cat owners surveyed were unaware that their cat was above a healthy weight.
Dechra Veterinary Products, maker of the feline hyperthyroidism treatment Felimazole®, has launched a range of waiting room materials for practices to raise awareness with owners about the disease.
Using Dechra's cartoon cat, which already features in their client booklets on feline hyperthyroidism, the materials are intended to create a focal point in the waiting room, with factual posters detailing what feline hyperthyroidism is and the symptoms to look out for. Also included is a selection of display enhancers.
The new waiting room display has been designed to complement Dechra's existing materials: client booklets, the website www.hyperthyroidcat.co.uk, website posters and hand-out cards.
Matthew Olsen, product manager at Dechra Veterinary Products said: "Our complete range of materials makes it easier for practices to communicate with owners on the subject and will help owners better understand and manage hyperthyroidism in their cats".
Practices can order their pack of waiting room materials by contacting Dechra on 01743 441632 or email marketing@dechra.com.
Dechra Veterinary Products has launched a new 50 ml bottle of its rapid acting dissociative anaesthetic licensed for cats, dogs and horses, Anesketin.
Anesketin solution for injection, containing Ketamine 100 mg/ml, is indicated for induction of anaesthesia.
Dechra Brand Manager Craig Sankey said: "Anesketin has proved to be a very popular product in our range due to its versatility. It can be used in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction of anaesthesia.
"As it does not require any special temperature storage conditions it makes it a very portable product for vets on the move."
He added: "We are very pleased to be able to add the larger Anesketin product to our wide range of analgesics and sedatives. This demonstrates our commitment to offering high quality products that support vets in small animal and equine practice."
Dechra says the product can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in cats.
Anesketin is also available in 10 ml vials. For further information, visit www.dechra.co.uk
The group is hoping to raise more than £5,000 for the hospital by donating £1 for every pet vaccinated at its West Derby, Gateacre, St Helens and Widnes practices over the next four months.
Sarah Kirkman MRCVS, from White Cross Vets in Gateacre, said: "It’s our job to care for pets, but we also really care about the communities in which we operate, and we have a real affinity with the hospital. This partnership means we’re protecting pets, by vaccinating them against a wide range of nasty diseases, as well as raising money to support the invaluable work that the hospital does."
Allan Eves from Alder Hey Children’s Charity said: "We care for over 275,000 children, young people and their families treating everything from common illnesses to highly complex and specialist conditions. We also lead research into children’s medicines, infection, inflammation and oncology and our charity has raised over £22m to support Alder Hey Children’s Hospital, funding life-saving medical equipment, research and vital facilities. We are so pleased to be working with White Cross Vets on this superb fund-raising initiative and can’t wait to meet the vets and nurses who are helping us."
Sarah added: "We are aiming to raise £5,000, but it could be more. We also want to support the hospital’s therapy dog by providing them with our Complete Wellness Plan for free. The plan provides free health-checks, veterinary care and preventative treatment on an ongoing basis. We already give free membership to several Fire Service Search Dog Teams, as we feel it’s really important to look after these amazing dogs which dedicate their lives to help people."
The charitable campaign is running from the 4th September until the 31st December and plans are also in place for the veterinary surgeons and nurses from White Cross Vets to visit the hospital regularly to talk to the children about pets.
Sarah said: "We give every one of our team four paid donation days a year, so that they can volunteer with a charity of their choice, and we are keen to further our partnership with the hospital by visiting regularly. We already do this in numerous schools across the region and know just how much children love to find out about our day to day roles, and they always have plenty of interesting questions for our nurses and vets to answer."
The £11m project, which is backed by Mars Petcare, will include a cutting-edge imaging suite, state-of-the-art treatment facilities and a new linear accelerator.
Plans also include separate cat and dog waiting areas and client walking and comfort areas, seven operating theatres, 15 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and plans for a future hydrotherapy suite.
Daniel Hogan, operations manager at Southfields (pictured right), said: "This is a really exciting time for Southfields and our relocation will provide the region with one of the largest and best-equipped veterinary centres in the UK.
"The team and expertise have grown significantly in the past 18 months. We are very excited to continue to expand the unique and innovative offerings in patient care at our centre.
"Increasing in size will also enable us to provide a dedicated staff wellbeing area and an education centre and lecture hall, which will offer some very exciting qualifications and courses for the wider profession.
"Since our rebranding in 2017, we pride ourselves on leading the industry as a truly multidisciplinary centre with specialists from across the globe, including one of the most illustrious oncology teams in the country. Once this new site is launched, we will be able to offer an even more comprehensive service to our clients and patients."
For more information about Southfields, visit www.southfields.co.uk.